Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Association between high cystatin C levels and carotid atherosclerosis.

Kobayashi T, Yokokawa H, Fujibayashi K, Haniu T, Hisaoka T, Fukuda H, Naito T.

World J Cardiol. 2017 Feb 26;9(2):174-181. doi: 10.4330/wjc.v9.i2.174.

2.

Protocol for Evaluating the Cardio-Ankle Vascular Index to Predict Cardiovascular Events in Japan: A Prospective Multicenter Cohort Study.

Miyoshi T, Ito H, Horinaka S, Shirai K, Higaki J, Orimio H.

Pulse (Basel). 2017 Jan;4(Suppl 1):11-16. doi: 10.1159/000448464. Epub 2016 Dec 23. Review.

3.

Efficacy and Safety of Combination Therapy Consisting of Angiotensin II Type 1 Receptor Blocker, Calcium Channel Blocker and Hydrochlorothiazide in Patients With Hypertension.

Shiga Y, Miura SI, Motozato K, Yoshimine Y, Norimatsu K, Arimura T, Koyoshi R, Morii J, Kuwano T, Inoue K, Shirotani T, Fujisawa K, Matsunaga E, Saku K.

J Clin Med Res. 2017 Feb;9(2):98-103. doi: 10.14740/jocmr2838w. Epub 2016 Dec 31.

4.

Safety and Antihypertensive Effect of Selara® (Eplerenone): Results from a Postmarketing Surveillance in Japan.

Takahashi S, Hiramatsu M, Hotta S, Watanabe Y, Suga O, Endo Y, Miyamori I.

Int J Hypertens. 2016;2016:5091951. Epub 2016 Oct 24.

5.

Efficacy and Safety of a Single-Pill Fixed-Dose Combination of Azilsartan and Amlodipine.

Motozato K, Miura SI, Shiga Y, Kusumoto T, Saku K.

J Clin Med Res. 2016 Dec;8(12):888-892. Epub 2016 Oct 26.

6.

7th Brazilian Guideline of Arterial Hypertension: Chapter 2 - Diagnosis and Classification

Malachias MVB, Gomes MAM, Nobre F, Alessi A, Feitosa AD, Coelho EB.

Arq Bras Cardiol. 2016 Sep;107(3 Suppl 3):7-13. doi: 10.5935/abc.20160152. English, Portuguese. No abstract available.

7.

Effects of Tooth Loss and the Apolipoprotein E ɛ4 Allele on Mild Memory Impairment in the Fujiwara-kyo Study of Japan: A Nested Case-Control Study.

Okamoto N, Morikawa M, Amano N, Yanagi M, Takasawa S, Kurumatani N.

J Alzheimers Dis. 2017;55(2):575-583.

9.

Impact of Blood Pressure Control on Thromboembolism and Major Hemorrhage in Patients With Nonvalvular Atrial Fibrillation: A Subanalysis of the J-RHYTHM Registry.

Kodani E, Atarashi H, Inoue H, Okumura K, Yamashita T, Otsuka T, Tomita H, Origasa H; J‐RHYTHM Registry Investigators..

J Am Heart Assoc. 2016 Sep 12;5(9). pii: e004075. doi: 10.1161/JAHA.116.004075.

10.

Renin-Angiotensin System Control for Chronic Kidney Disease Patients Undergoing Coronary Surgery.

Yoshitake I, Sezai A, Hata M, Osaka S, Kimura H, Hata H, Shiono M.

Ann Thorac Cardiovasc Surg. 2016 Oct 20;22(5):291-297. Epub 2016 Aug 23.

11.

Increased cardiovascular risk of treated white coat and masked hypertension in patients with diabetes and chronic kidney disease: the HONEST Study.

Kushiro T, Kario K, Saito I, Teramukai S, Sato Y, Okuda Y, Shimada K.

Hypertens Res. 2017 Jan;40(1):87-95. doi: 10.1038/hr.2016.87. Epub 2016 Aug 11.

12.

Renoprotective effects of renin-angiotensin system inhibitor combined with calcium channel blocker or diuretic in hypertensive patients: A PRISMA-compliant meta-analysis.

Cheng Y, Huang R, Kim S, Zhao Y, Li Y, Fu P.

Medicine (Baltimore). 2016 Jul;95(28):e4167. doi: 10.1097/MD.0000000000004167.

13.

Evaluation of Criteria to Detect Masked Hypertension.

Booth JN 3rd, Muntner P, Diaz KM, Viera AJ, Bello NA, Schwartz JE, Shimbo D.

J Clin Hypertens (Greenwich). 2016 Nov;18(11):1086-1094. doi: 10.1111/jch.12830. Epub 2016 Apr 29.

14.

Dyslipidemia and the Risk of Developing Hypertension in a Working-Age Male Population.

Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K, Kawada T.

J Am Heart Assoc. 2016 Mar 25;5(3):e003053. doi: 10.1161/JAHA.115.003053.

15.

A U-shaped relationship between alcohol consumption and cardiometabolic index in middle-aged men.

Wakabayashi I.

Lipids Health Dis. 2016 Mar 9;15:50. doi: 10.1186/s12944-016-0217-4.

16.

Comparison of Clinical Trajectories before Initiation of Renal Replacement Therapy between Diabetic Nephropathy and Nephrosclerosis on the KDIGO Guidelines Heat Map.

Abe M, Okada K, Maruyama N, Takashima H, Oikawa O, Soma M.

J Diabetes Res. 2016;2016:5374746. doi: 10.1155/2016/5374746. Epub 2015 Dec 29.

17.

Influence of angiotensin II receptor blocker combination tablet prescription on drug number and cost.

Teramachi H, Takahashi T, Tachi T, Noguchi Y, Nagasawa H, Ino Y, Mizui T, Goto C, Tsuchiya T.

SAGE Open Med. 2014 Dec 22;2:2050312114563318. doi: 10.1177/2050312114563318. eCollection 2014 Dec 22.

18.

Association Between Interleukin-6 -572 C>G and -174 G>C Polymorphisms and Hypertension: A Meta-analysis of Case-control Studies.

Ma H, Sun G, Wang W, Zhou Y, Liu D, Tong Y, Lu Z.

Medicine (Baltimore). 2016 Jan;95(2):e2416. doi: 10.1097/MD.0000000000002416. Review.

19.

Persistent olmesartan-based blood pressure-lowering effects on morning hypertension in Asians: the HONEST study.

Kario K, Saito I, Kushiro T, Teramukai S, Yaginuma M, Mori Y, Okuda Y, Kobayashi F, Shimada K.

Hypertens Res. 2016 May;39(5):334-41. doi: 10.1038/hr.2015.148. Epub 2016 Jan 7.

20.

Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial.

Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events COPE Trial Group..

Hypertens Res. 2016 Jan;39(1):46-53. doi: 10.1038/hr.2015.104. Epub 2015 Oct 22.

Supplemental Content

Support Center